Clinical Trials & COVID-19

Targeted HER2 Macrophage Cell Therapy

What is the study therapy?

The study therapy is designed to target HER2 protein overexpression, which can cause cancer cells to rapidly grow and form solid tumors. The study therapy is made from your own macrophage cells, which are a type of immune cell that helps protect you from infections.

Macrophage cells can also help the immune system guard against cancer. However, once a cancer starts to grow and spread, the macrophages and other cells in your immune system may not be powerful enough to effectively recognize and attack all the tumor cells. The macrophage cell therapy may help support your body’s immune system in its fight against different kinds of cancer, including the following:

  • Breast cancer
  • Prostate cancer
  • Head and Neck cancer
  • Gastro-esophageal cancer
  • Lung cancer (small cell and non-small cell)
  • Colorectal cancer
  • Ovarian cancer
  • Endometrial cancer
  • Pancreatic cancer
  • Urethral/bladder cancer
  • Gallbladder cancer
HER2 Overexpression

What is an investigational cancer therapy?

An “investigational” cancer therapy is a therapy that has not been approved as a standard treatment. These therapies are still being researched in clinical trials to make sure they are safe and effective.

Regulatory authorities, such as the US Food and Drug Administration (FDA), must approve an investigational therapy before it can be used to treat cancer.

About Clinical Trials